genotype and antipsychotic-induced extrapyramidal side effects in schizophrenic patients

By Scordo M.G.   Spina E.   Romeo P.   Dahl M.-L.   Bertilsson L.   Johansson I.   Sjöqvist F.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 679-683

Springer Publishing Company

Access to resources Recommend Favorite

Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients

By Gunes Arzu   Scordo Maria   Jaanson Peeter   Dahl Marja-Liisa  

Psychopharmacology, Vol. 190, Iss. 4, 2007-03 ,pp. : 479-484

Springer Publishing Company

Access to resources Recommend Favorite

Further evidence for the association between 5-HT_2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients

By Gunes Arzu   Dahl Marja-Liisa   Spina Edoardo   Scordo Maria  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 5, 2008-05 ,pp. : 477-482

Springer Publishing Company

Access to resources Recommend Favorite

Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine

By Tada Miho   Shirakawa Kiyoharu   Matsuoka Nobuya   Mutoh Seitaro  

Psychopharmacology, Vol. 176, Iss. 1, 2004-10 ,pp. : 94-100

Springer Publishing Company

Access to resources Recommend Favorite

Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial

By Mazza Marianna   Squillacioti Maria Rosaria   Pecora Riccardo Daniele   Janiri Luigi   Bria Pietro  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3145-3149

Informa Healthcare

Access to resources Recommend Favorite